SET and colorectal carcinoma: As with previous observations in metastatic CRC, which evidenced how miR-199b was downregulated in around 50% of SET-overexpressing cases, here we observed that miR-199b downregulation was significantly associated with SET overexpression and that 4 out of 7 CRC patients with SET overexpression showed reduced miR-199b levels (Table S4).